It’s not always easy to figure out whether your software is 21 CFR Part 11 compliant or compatible. Regulations for 21 CFR Part 11 state that electronic records, electronic signatures, and handwritten signatures converted into digital copies are all trustworthy, reliable, and equal to handwritten signatures on paper.
A lab disaster can come in the form of a fire, tornado, loss of electricity, cyber attack, compromised assay components, or more. With profitability and results on the line, many pharma labs are taking steps to develop disaster prevention strategies as well as carefully thought-out response plans.
When most of us encounter bacteria, we reach for a sanitizer. Researchers at the Cork Cancer Research Centre in Cork, Ireland, have a much different reaction. They view these single-cell microorganisms as literal torchbearers in advancing new therapies for infectious diseases especially as it relates to cancer.
Hybrid approaches to lab management are now becoming the norm, globally, with the lure and benefit of promising a more efficient, optimal operation within labs – including reducing undue burden on lab managers.
Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe.
A group of scientists at the Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed a new microscopy technique for blood cells that saves time, money, and, most importantly, is already helping to uncover new immunotherapy treatments for cancer.
The nanotech world just witnessed a revolution. For the first time in history, scientists at the University of South Carolina’s Center for Environmental NanoScience and Risk (CENR) and PerkinElmer have precisely quantified the uptake of metal nanoparticles by individual cells.
Researchers have developed an optimized and validated routine method for collecting stool samples to extract DNA for the first time. The method uses PerkinElmer's chemagic MSM I extraction instrument and is expected to accelerate microbiome research.
Research at Institut Pasteur de Lille using PerkinElmer’s Opera® High-Content Screening System and Acapella® Image Analysis Software contributes substantial new information to our understanding of M. tuberculosis.
Scientists at UCLA's David Geffen School of Medicine are working with bioluminescent, fluorescent, and positron emission tomography (PET) technologies to reduce infections in post-surgical orthopedic patients as well as fight against metabolic cancer.